MAP PHARMACEUTICALS, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 46 rows in 2010. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2010-12-20: Reporting owner Friedman Charlene A; Form 4; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2010-12-15: Reporting owner GIANAKAKOS ANASTASIOS; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2010-10-27: Reporting owner Friedman Charlene A; Form 4; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2010-10-27: Reporting owner HENWOOD GERALDINE; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2010-12-20 | Friedman Charlene A Officer (VP President, Gen Counsel &Sec) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,120 38,828 owned after | $10.37 exercise price | 2010-12-21 | |
| 2010-12-15 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,500 15,328 owned after | $0.74 exercise price | 2010-12-17 | |
| 2010-10-27 | Friedman Charlene A Officer (VP President, Gen Counsel &Sec) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,800 41,948 owned after | $10.37 exercise price | 2010-10-29 | |
| 2010-10-27 | HENWOOD GERALDINE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,627 0 owned after | $0.64 exercise price | 2010-10-29 | |
| 2010-10-27 | HENWOOD GERALDINE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,387 1,490 owned after | $0.74 exercise price | 2010-10-29 | |
| 2010-10-27 | HENWOOD GERALDINE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,750 3,750 owned after | $3.18 exercise price | 2010-10-29 | |
| 2010-09-20 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,000 55,122 owned after | $0.74 exercise price | 2010-09-22 | |
| 2010-09-01 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,250 18,143 owned after | $0.74 exercise price | 2010-09-03 | |
| 2010-08-05 | HENWOOD GERALDINE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,000 5,877 owned after | $0.74 exercise price | 2010-08-06 | |
| 2010-08-02 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,250 21,393 owned after | $0.74 exercise price | 2010-08-02 | |
| 2010-07-21 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,000 71,122 owned after | $0.74 exercise price | 2010-07-22 | |
| 2010-07-20 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,000 79,122 owned after | $0.74 exercise price | 2010-07-22 | |
| 2010-07-01 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,250 24,643 owned after | $0.74 exercise price | 2010-07-02 | |
| 2010-07-01 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 232,549 owned after | $0.64 exercise price | 2010-07-02 | |
| 2010-06-03 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,480 247,549 owned after | $0.64 exercise price | 2010-06-03 | |
| 2010-06-01 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,520 251,029 owned after | $0.64 exercise price | 2010-06-03 | |
| 2010-06-01 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,250 27,893 owned after | $0.74 exercise price | 2010-06-03 | |
| 2010-05-20 | ELMS STEVE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.77 exercise price | 2010-05-24 | |
| 2010-05-20 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,000 87,122 owned after | $0.74 exercise price | 2010-05-21 | |
| 2010-05-20 | Wolff Henry Ward Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.77 exercise price | 2010-05-21 | |
| 2010-05-20 | WARD SCOTT R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.77 exercise price | 2010-05-21 | |
| 2010-05-20 | KELLEY BERNARD J Director | 4 | Stock Option (right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.77 exercise price | 2010-05-21 | |
| 2010-05-20 | HENWOOD GERALDINE Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.77 exercise price | 2010-05-21 | |
| 2010-05-20 | GOLDFISCHER CARL Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.77 exercise price | 2010-05-21 | |
| 2010-05-20 | Freund John Gordon Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.77 exercise price | 2010-05-21 | |
| 2010-05-20 | MCPHERRON MATTHEW V Director, 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,500 7,500 owned after | $14.77 exercise price | 2010-05-21 | |
| 2010-05-13 | Friedman Charlene A Officer (VP President, Gen Counsel &Sec) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,560 49,748 owned after | $10.37 exercise price | 2010-05-14 | |
| 2010-05-13 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 277,549 owned after | $0.64 exercise price | 2010-05-14 | |
| 2010-05-03 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,250 31,143 owned after | $0.74 exercise price | 2010-05-05 | |
| 2010-04-26 | Friedman Charlene A Officer (VP President, Gen Counsel &Sec) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,155 51,308 owned after | $10.37 exercise price | 2010-04-28 | |
| 2010-04-14 | Friedman Charlene A Officer (VP President, Gen Counsel &Sec) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,560 61,463 owned after | $10.37 exercise price | 2010-04-15 | |
| 2010-04-01 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,250 34,393 owned after | $0.74 exercise price | 2010-04-05 | |
| 2010-03-24 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,000 103,122 owned after | $0.74 exercise price | 2010-03-25 | |
| 2010-03-23 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,000 111,122 owned after | $0.74 exercise price | 2010-03-25 | |
| 2010-03-01 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,250 37,643 owned after | $0.74 exercise price | 2010-03-03 | |
| 2010-03-01 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 307,549 owned after | $0.64 exercise price | 2010-03-03 | |
| 2010-02-02 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $16.19 exercise price | 2010-02-04 | |
| 2010-02-02 | ARMER THOMAS A Director, Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $16.19 exercise price | 2010-02-04 | |
| 2010-02-02 | Friedman Charlene A Officer (VP President, Gen Counsel &Sec) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $16.19 exercise price | 2010-02-04 | |
| 2010-02-02 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | −45,000 45,000 owned after | $16.19 exercise price | 2010-02-04 | |
| 2010-02-02 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $16.19 exercise price | 2010-02-04 | |
| 2010-02-02 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +55,000 55,000 owned after | $16.19 exercise price | 2010-02-04 | |
| 2010-02-01 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,250 58,721 owned after | $0.74 exercise price | 2010-02-03 | |
| 2010-01-15 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 22,828 owned after | $0.74 exercise price | 2010-01-19 | |
| 2010-01-11 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 337,549 owned after | $0.64 exercise price | 2010-01-13 | |
| 2010-01-04 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,500 44,143 owned after | $0.74 exercise price | 2010-01-06 |